Literature DB >> 25075628

Highly biocompatible zwitterionic phospholipids coated upconversion nanoparticles for efficient bioimaging.

Chi Yao1, Peiyuan Wang, Lei Zhou, Rui Wang, Xiaomin Li, Dongyuan Zhao, Fan Zhang.   

Abstract

The potential of upconversion nanoparticles (UCNPs) in various biomedical applications, including immunoassays, biomedical imaging, and molecular sensing, requires their surface derivatized to be hydrophilic and biocompatible. Here, a new family of compact zwitterionic ligand systems composed with functional phospholipids was designed and used for the surface modification of UCNPs. The zwitterionic UCNPs are hydrophilic, compact, and easily functionalized. It was proved that zwitterionic phospholipids could provide UCNPs with not only extended pH and salt stability but also little nonspecific interactions to positively and negatively charged proteins, low nonspecific adhesion in live-cell imaging process. Most notably, the efficient in vivo tumor imaging performance and long blood circulation half-life suggests the excellent biocompatibility for in vivo imaging of the zwitterionic UCNPs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25075628     DOI: 10.1021/ac5023259

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  10 in total

1.  Principles of nanoparticle design for overcoming biological barriers to drug delivery.

Authors:  Elvin Blanco; Haifa Shen; Mauro Ferrari
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908

2.  In vivo gastrointestinal drug-release monitoring through second near-infrared window fluorescent bioimaging with orally delivered microcarriers.

Authors:  Rui Wang; Lei Zhou; Wenxing Wang; Xiaomin Li; Fan Zhang
Journal:  Nat Commun       Date:  2017-03-10       Impact factor: 14.919

Review 3.  Lanthanide-Doped Upconversion Nanocarriers for Drug and Gene Delivery.

Authors:  Gibok Lee; Yong Il Park
Journal:  Nanomaterials (Basel)       Date:  2018-07-09       Impact factor: 5.076

4.  Fabrication of Red Blood Cell-Based Multimodal Theranostic Probes for Second Near-Infrared Window Fluorescence Imaging-Guided Tumor Surgery and Photodynamic Therapy.

Authors:  Peiyuan Wang; Xuandong Wang; Qiang Luo; Yang Li; Xiaoxiao Lin; Lingling Fan; Yun Zhang; Jingfeng Liu; Xiaolong Liu
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

5.  Metal Organic Frame-Upconverting Nanoparticle Assemblies for the FRET Based Sensor Detection of Bisphenol A in High-Salt Foods.

Authors:  Zhou Xu; Lin-Wei Zhang; Ling-Li Long; Shao-Hua Zhu; Mao-Long Chen; Li Ding; Yun-Hui Cheng
Journal:  Front Bioeng Biotechnol       Date:  2020-12-22

6.  Nanoparticle induced formation of self-assembled zwitterionic surfactant microdomains which mimic microemulsions for the in situ fabrication and dispersion of silver nanoparticles.

Authors:  Taichi Nakagawa; Akihide Hibara; Willie L Hinze; Yoshitaka Takagai
Journal:  RSC Adv       Date:  2020-09-15       Impact factor: 4.036

7.  Mechanism Study on Nanoparticle Negative Surface Charge Modification by Ascorbyl Palmitate and Its Improvement of Tumor Targeting Ability.

Authors:  Lin Li; Hongliang Wang; Jun Ye; Yankun Chen; Renyun Wang; Dujia Jin; Yuling Liu
Journal:  Molecules       Date:  2022-07-09       Impact factor: 4.927

8.  Multifunctional NaYF4:Nd/NaDyF4 nanocrystals as a multimodal platform for NIR-II fluorescence and magnetic resonance imaging.

Authors:  Junwei Zhao; Huishan Hu; Wenquan Liu; Xin Wang
Journal:  Nanoscale Adv       Date:  2020-12-09

Review 9.  Native and bioengineered extracellular vesicles for cardiovascular therapeutics.

Authors:  Ricardo Cerqueira de Abreu; Hugo Fernandes; Paula A da Costa Martins; Susmita Sahoo; Costanza Emanueli; Lino Ferreira
Journal:  Nat Rev Cardiol       Date:  2020-06-01       Impact factor: 32.419

10.  NIR-II nanoprobes in-vivo assembly to improve image-guided surgery for metastatic ovarian cancer.

Authors:  Peiyuan Wang; Yong Fan; Lingfei Lu; Lu Liu; Lingling Fan; Mengyao Zhao; Yang Xie; Congjian Xu; Fan Zhang
Journal:  Nat Commun       Date:  2018-07-24       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.